| Mon, Dec 7, 2009 | | • | OXiGENE Reports Promising Preclinical Data Using OXi4503 in Acute Myelogenous Leukemia Models at ASH Conference
GlobeNewswire (Mon, Dec 7)
| | Tue, Nov 17, 2009 | | • | OXiGENE Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2009 AACR-NCI-EORTC Conference
GlobeNewswire (Tue, Nov 17)
| | Thu, Nov 12, 2009 | | • | OXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC Meetings
GlobeNewswire (Thu, Nov 12)
| | Tue, Nov 10, 2009 | | • | OXiGENE to Present at Merriman Curhan Ford and Lazard Healthcare Conferences
GlobeNewswire (Tue, Nov 10)
| | Mon, Nov 9, 2009 | | • | OXiGENE Reports Third Quarter 2009 Financial Results
GlobeNewswire (Mon, Nov 9)
| | Tue, Nov 3, 2009 | | • | OXiGENE Announces Third Quarter 2009 Earnings Conference Call and Webcast
GlobeNewswire (Tue, Nov 3)
| | Thu, Oct 15, 2009 | | • | OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger
GlobeNewswire (Thu, Oct 15)
| | Mon, Oct 12, 2009 | | • | OXiGENE Announces Data Presentation At 2009 AACR-EORTC-NCI Conference
GlobeNewswire (Mon, Oct 12)
| | Thu, Oct 8, 2009 | | • | Oxigene Announces Management Changes
GlobeNewswire (Thu, Oct 8)
| | Thu, Jul 30, 2009 | | • | OXiGENE Reports Second Quarter 2009 Financial Results; Company Continues to Achieve Pipeline Progress With Strengthened Cash Position
GlobeNewswire (Thu, Jul 30)
| | Fri, Jul 24, 2009 | | • | OXiGENE Announces Second Quarter 2009 Earnings Conference Call and Webcast
GlobeNewswire (Fri, Jul 24)
| | Tue, Jul 21, 2009 | | • | OXiGENE Announces Closing of Registered Direct Offering
GlobeNewswire (Tue, Jul 21)
| | Wed, Jul 15, 2009 | | • | OXiGENE to Raise $10 Million in Registered Direct Offering
GlobeNewswire (Wed, Jul 15)
| | Mon, Jul 6, 2009 | | • | OXiGENE Announces Agreement to Acquire Symphony ViDA, Including More Than $12 Million in Unrestricted Cash and All Rights to OXi4503 and ZYBRESTAT for Ophthalmology
GlobeNewswire (Mon, Jul 6)
| | Thu, Jun 25, 2009 | | • | OXiGENE Initiates Phase 2 Trial of ZYBRESTAT for Ophthalmology
GlobeNewswire (Thu, Jun 25)
| | Wed, Jun 17, 2009 | | • | OXiGENE Appoints Dr. Peter J. Langecker as Chief Development Officer
GlobeNewswire (Wed, Jun 17)
| | Mon, Jun 1, 2009 | | • | OXiGENE Reports Positive Data From Phase 2 Trial of ZYBRESTAT in Platinum Resistant Ovarian Cancer At the 2009 ASCO Annual Meeting
GlobeNewswire (Mon, Jun 1)
| | Thu, May 21, 2009 | | • | OXiGENE Announces Clinical Data to be Presented At the 2009 Annual Meeting of the American Society of Clinical Oncology
GlobeNewswire (Thu, May 21)
| | Mon, May 11, 2009 | | • | OXiGENE Reports First Quarter 2009 Financial Results
GlobeNewswire (Mon, May 11)
| | Mon, May 4, 2009 | | • | OXiGENE Announces First Quarter 2009 Earnings Conference Call and Webcast
GlobeNewswire (Mon, May 4)
|
Add OXGN.ST News to My Yahoo!:
 
| |
|
0.49% Nasdaq 
Headlines
